Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epstein-Barr Virus (EBV) -Specific T Memory Stem Cell (Tscm) Therapy to Treat EBV- Driven Lymphomas/ Diseases

NCT05688241 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.

NCT NCT05688241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05688241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epstein-Barr Virus (EBV) -Specific T Memory Stem Cell (Tscm) Therapy to Treat EBV- Driven Lymphomas/ Diseases
Lead sponsor
University Hospital, Basel, Switzerland
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
December 31, 2031
Enrollment
10 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

ebv lymphoma, post-transplant lymphoproliferative disease (ptld)